Pharmaseed, Model BT-103-3

FDA 510(k) K994016 · Syncor Pharmaceuticals, Inc.

Substantially Equivalent

510(k) numberK994016

Submission

Device name
Pharmaseed, Model BT-103-3
Applicant
Syncor Pharmaceuticals, Inc.
Golden, CO, US
Received
November 26, 1999
Decision date
July 14, 2000
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) statement available from FDA

Official FDA 510(k) record

Device classification

Product code
KXK – Source, Brachytherapy, Radionuclide
Device class
Class II (moderate risk)
Regulation
21 CFR 892.5730
Specialty
Radiology
Implant
Yes

Other 510(k)s with product code KXK

510(k)DeviceApplicantDecision
K252296OncoPatchKXK · Traditional Oncopatch, Inc.12/05/2025SE
K242818IsoSphereKXK · Traditional Isoaid, LLC07/15/2025SE
K223465RadianceTx Radionuclide Brachytherapy SourceKXK · Traditional Radiance Therapeutics, Inc.01/11/2023SE
K221539GammaTileKXK · Traditional Gt Medical Technologies11/09/2022SE
K202267Sirius MRI Markers, Cs-131 Preloaded Strands with Sirius MRI Markers in 18 Gauge NeedlesKXK · Traditional Isoray Medical, Inc.12/31/2020SE
K193602LV Liberty Vision Model 1 90Yttrium Brachytherapy SourceKXK · Special Lv Liberty Vision Corporation05/29/2020SE
K190839GammaTileKXK · Traditional Gt Medical Technologies01/23/2020SE
K191324CivaDermKXK · Traditional Civatech Oncology, Inc.09/20/2019SE
K190296GammaTileKXK · Special Gt Medical Technologies03/13/2019SE
K180515GammaTileKXK · Traditional Isoray Medical, Inc.07/06/2018SE

More from Isoray Medical, Inc.

510(k)DeviceDecision
K994018Pharmaseed, Model BT-125-3KXK · Traditional 07/17/2000SE
K992007Pharmaseed, Model BT-103-1KXK · Traditional 01/14/2000SE
K992008Pharmaseed, Model BT-125-1KXK · Traditional 12/23/1999SE

Questions and answers

When was Pharmaseed, Model BT-103-3 cleared by the FDA?

Pharmaseed, Model BT-103-3 (K994016) received a 510(k) decision of Substantially Equivalent on July 14, 2000, 231 days after the submission was received.

What is the product code of K994016?

The FDA product code is KXK – Source, Brachytherapy, Radionuclide, a Class II (moderate risk) device regulated under 21 CFR 892.5730.